Progenesis Ivf Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 25-07-2024
- Paid Up Capital ₹ 0.10 M
as on 25-07-2024
- Company Age 5 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 81.05%
(FY 2023)
- Profit 64.20%
(FY 2023)
- Ebitda 67.93%
(FY 2023)
- Net Worth 133.58%
(FY 2023)
- Total Assets 80.11%
(FY 2023)
About Progenesis Ivf
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Narhari Malagaonkar, Prashant Aher, and Sandeep Aher serve as directors at the Company.
- CIN/LLPIN
U85320MH2019PTC330820
- Company No.
330820
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
20 Sep 2019
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Thane, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Progenesis Ivf?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sandeep Aher  | Director | 20-Sep-2019 | Current |
| Narhari Malagaonkar | Director | 20-Sep-2019 | Current |
| Prashant Aher | Director | 20-Sep-2019 | Current |
Financial Performance of Progenesis Ivf.
Progenesis Ivf Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 81.05% increase. The company also saw a substantial improvement in profitability, with a 64.2% increase in profit. The company's net worth Soared by an impressive increase of 133.58%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Progenesis Ivf?
In 2023, Progenesis Ivf had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Parmaz Landmark Two LlpActive 5 years 1 monthNarhari Malagaonkar, Prashant Aher and 1 more are mutual person
- Hariprasanna Properties LlpActive 3 years 8 months
Narhari Malagaonkar, Prashant Aher and 1 more are mutual person
- Snup Properties LlpActive 3 years 2 months
Narhari Malagaonkar, Prashant Aher and 1 more are mutual person
- Kalaprasanna Avenue LlpActive 2 years 12 days
Narhari Malagaonkar, Prashant Aher and 1 more are mutual person
- Progenesis FoundationActive 2 years 3 months
Narhari Malagaonkar, Prashant Aher and 1 more are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Progenesis Ivf?
Progenesis Ivf has a workforce of 42 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Progenesis Ivf, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Progenesis Ivf's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
